Dr. Reddy's Laboratories Share Price
1164.20+9.20 (+0.80%)
-7.76% past 1 Year
Dr. Reddy’s Laboratories is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global
Corporate filings & documents
Announcements
Allotment of Employee Stock options
1 week agoAllotment of Employee Stock options
1 week agoCopies of newspaper publication
2 weeks agoCopies of newspaper publication
2 weeks agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
2 weeks agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
3 weeks agoChange in Senior Management Personnel
3 weeks agoChange in Senior Management Personnel
3 weeks agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2105
3 weeks agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2105
3 weeks agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
3 weeks agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Press Release
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Press Release
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoClarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoClarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoTranscript of Earnings call recording
1 month agoThe Exchange has sought clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.business-standard.com dated July 28 2026 (Link:https://www.business-standard.com/companies/news/dr-reddys-first-in-class-gonorrhoea-drug-gets-thailand-approval-after-us-nod-126072700632_1.html) titled "Dr Reddys antibiotic gets Thailand approval six months after US nod".<BR><BR>The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations 2015.
1 month agoThe Exchange has sought clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.business-standard.com dated July 28 2026 (Link:https://www.business-standard.com/companies/news/dr-reddys-first-in-class-gonorrhoea-drug-gets-thailand-approval-after-us-nod-126072700632_1.html) titled "Dr Reddys antibiotic gets Thailand approval six months after US nod".<BR><BR>The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations 2015.
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulation 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulation 2015
1 month agoScrutinizers Report
1 month agoScrutinizers Report
1 month agoOutcome of 42nd Annual General Meeting
1 month agoOutcome of 42nd Annual General Meeting
1 month agoCopy of newspaper publication
1 month agoCopy of newspaper publication
1 month agoIntimation of Earnings call recordings
1 month agoIntimation of Earnings call recordings
1 month agoCopy of Investor Presentation
1 month agoCopy of Investor Presentation
1 month agoGrant of Employee Stock Options
1 month agoGrant of Employee Stock Options
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoUnaudited Financial results for the quarter ended June 30 2026
1 month agoUnaudited Financial results for the quarter ended June 30 2026
1 month agoOutcome of Board Meeting held on July 22 2026
1 month agoOutcome of Board Meeting held on July 22 2026
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Conference Call Transcript
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Conference Call Transcript
1 month agoIntimation of Earnings call
1 month agoIntimation of Earnings call
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoDisclosure under Regulation 30 of SEBI (LODR) Regulations 2015
1 month agoConcalls & investor presentations
Jul 2026
May 2026
Jan 2026
Oct 2025
ConcallPresentation
Jul 2025
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Oct 2023
ConcallPresentation
Jul 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Oct 2022
ConcallPresentation
Jul 2022
ConcallPresentation
May 2022
Jan 2022
Oct 2021
Jul 2021
May 2021
Jan 2021
Oct 2020
Corporate Actions
Date
Type
Details
2026-07-10
Dividend
8.0
2025-07-10
Dividend
8.0
2024-10-28
Split
5:1
2024-07-16
Dividend
40.0
2023-07-11
Dividend
40.0
2022-07-11
Dividend
30.0
2021-07-09
Dividend
25.0
2020-07-13
Dividend
25.0
2019-07-15
Dividend
20.0
2018-07-16
Dividend
20.0
2017-07-17
Dividend
20.0
2016-07-18
Dividend
20.0
2015-07-10
Dividend
20.0
2014-07-11
Dividend
18.0
2013-07-12
Dividend
15.0
2012-06-28
Dividend
13.75
2011-06-30
Dividend
11.25
2010-07-02
Dividend
11.25
Company details
Registered office
8-2-337 Road No. 3 Banjara Hills Hyderabad Telangana PIN: 500034 Tel No: 040 - 4900 2900 Fax No: 040 - 4900 2999 Email: [email protected] / [email protected] Internet: www.drreddys.com
Registrars
306,Right Wing Amruta Ville, Opp: Yashoda Hospital,Raj Bhavan Road,Somajiguda,Hyderabad 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital Raj Bhavan Road Somajiguda PIN: Tel No: +91-40-23374967/23370295 Fax No: +91-40-23370295 Email: [email protected] Internet: www.bigshareonline.com
Management
K Randhir Singh, Company Secretary, Compliance Officer and Head-CSR
K Satish Reddy, Chairman
GV Prasad, Co-Chairman & Managing Director
Leo Puri, Lead Independent Director
Arun Kumar, Non Executive Independent Director
Claudio Albrecht, Non Executive Independent Director
K P Krishnan, Non Executive Independent Director
Penny Wan, Non Executive Independent Director
Sanjiv Mehta, Non Executive Independent Director
Shikha Sharma, Non Executive Independent Director
Alpna Seth, Non Executive Independent Director
Srikanth Velamakanni, Independent Director
Details
BSE 500124
NSE DRREDDY
ISIN INE089A01031